RNAi News and Research

RSS
Plant-derived siRNAs could bring a 'green revolution' in RNAi tools and therapeutics

Plant-derived siRNAs could bring a 'green revolution' in RNAi tools and therapeutics

Biologists unravel new role for nervous system in regeneration

Biologists unravel new role for nervous system in regeneration

Study describes vulnerability shared by large subset of cancer cell lines

Study describes vulnerability shared by large subset of cancer cell lines

Large-scale screen efficiently identifies drugs that are potent cancer-killers

Large-scale screen efficiently identifies drugs that are potent cancer-killers

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

Liver tissue model can help investigate the effects of RNA interference

Liver tissue model can help investigate the effects of RNA interference

Researchers outline targeted therapeutic strategy for triple-negative breast cancer

Researchers outline targeted therapeutic strategy for triple-negative breast cancer

New acute porphyria treatment shows promising results in clinical study

New acute porphyria treatment shows promising results in clinical study

RBSC announces partnership with Mitacs to develop and test yeast-based RNAi technology

RBSC announces partnership with Mitacs to develop and test yeast-based RNAi technology

Protein discovery could lead to mosquito "birth control"

Protein discovery could lead to mosquito "birth control"

Inhalable mRNA offers hope for patients with lung disease

Inhalable mRNA offers hope for patients with lung disease

Genetically modified pigs could limit replication of classical swine fever virus, study shows

Genetically modified pigs could limit replication of classical swine fever virus, study shows

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

Novel DNA nanoplatform delivers anticancer agents to multidrug-resistant tumors

RNAi therapy shown to alleviate preeclampsia in animal model

RNAi therapy shown to alleviate preeclampsia in animal model

New initiative may benefit entrepreneurs working to transform patient care

New initiative may benefit entrepreneurs working to transform patient care

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam announces positive results from Phase 1/2 study of lumasiran for treating primary hyperoxaluria-1

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam submits CTA application to MHRA to initiate Phase 1/2 study of ALN-AAT02

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam reports further progress on broadening the therapeutic potential of RNAi

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease